LIANE HERNANDEZ SANGRONIS: Open Payments
NPI 1568934792 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 25 payments from 13 companies in 2025. Trend: 2023 $395 · 2024 $216 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 4 | $108 |
| TOLMAR, INC. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Verity Pharmaceuticals Inc. | 2 | $56 |
| UROGEN PHARMA, INC. | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| Myriad Genetic Laboratories, Inc. | 1 | $42 |
| 180 Medical, Inc. | 1 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
Products named: XIAFLEX, JATENZO, GEMTESA, Tlando, PROLARIS, GENTLECATH, PYLARIFY, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
